United States· US:63629-8450_6499b998-74f4-43c3-b2b6-79ea40ab474f
Scopolamine Trandermal System
A scopolamine product containing scopolamine, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Scopolamine is registered in 3 of 19 countries.
Countries holding a registration under ATC N05CM05 (scopolamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Scopolamine · ATC N05CM05
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SCOPOLAMINE
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- N05CM05
- ATC class
- Scopolamine
- Defined daily dose
- 0.9 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1163629-8450-1
- ndc11636298450124 POUCH in 1 CARTON (63629-8450-1) / 1 PATCH, EXTENDED RELEASE in 1 POUCH (63629-8450-2)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for scopolamine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Scopolamine · interactions on record
335 records
- 7 severe
- 197 moderate
- 17 minor
- 114 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DextropropoxypheneN02AC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Scopolamine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHyoscine 1mg/72hours transdermal patchesImported
- NetherlandsScopoderm 1 mg/72 uur, pleister voor transdermaal gebruikBaxter B.V.
- NorwayScopodermBaxter Medical AB
- SwedenScopoderm 1 mg/72 timmar DepotplåsterBaxter Medical AB
- FranceBROMHYDRATE DE SCOPOLAMINE RENAUDIN 0,025 %, solution injectableLABORATOIRE RENAUDIN
- BelgiumBromhydrate de Scopolamine 0,25 mg/mlLaboratoires Sterop
- FinlandOftan-ScopolaminSanten Oy
- CanadaSCOPOLAMINE HYDROBROMIDE INJECTIONOMEGA LABORATORIES LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Scopolamine Hbr Sterop
- Germany · Boro-Scopol N, Scopoderm Tts
- Denmark · Scopoderm
- Spain · Escopolamina B. Braun
- Finland · Scopoderm
- France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
- United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
- Ireland · Hyoscine Injection Bp Ethypharm, Kwells
- Iceland · Scopoderm
- Luxembourg · Scopoderm Tts
- Malta · Kwells
- Netherlands · Scopoderm
- Norway · Scopoderm
- Sweden · Scopoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb3e3629-5d8b-4285-ba0f-2c703031c2d2 GET /v1/drugs/fb3e3629-5d8b-4285-ba0f-2c703031c2d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TRANSDERMAL",
"source": "ndc",
"strength": "1",
"substance": "SCOPOLAMINE",
"productndc": "63629-8450",
"dosage_form": "PATCH, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA078830",
"marketing_category": "ANDA"
}See everything about scopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.